Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 4;15(1):15597.
doi: 10.1038/s41598-025-99794-z.

Effect of hydrogen sulfide on alpha-synuclein aggregation and cell viability

Affiliations

Effect of hydrogen sulfide on alpha-synuclein aggregation and cell viability

Elena A Ostrakhovitch et al. Sci Rep. .

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative movement disorder characterized by nigrostriatal degeneration and aggregation of α-synuclein (α-Syn) with accumulation of insoluble aggregates in Lewy bodies. Familial mutations in α-Syn are associated with the development of PD. Accumulation of insoluble aggregates results in neuronal toxicity. Identification of compounds that inhibit seeding activity of α-Syn is of great importance. Here we investigate the potential of H2S donor, sodium hydrosulfide (NaHS), to inhibit α-Syn aggregation. We examined the effect of NaHS on fibril growth kinetics and the structural change of α-Syn fibrils formed by self-seeding and cross-seeding of wild-type (wt) and PD familial α-Syn mutations. NaHS slowed both self- and cross-seeded A53T α-Syn fibril formation but not wild-type fibril formation. We observed a decrease in the formed fibril length in vitro. We examined the effect on fibril formation within cells. NaHS significantly reduced the number and filament length of formed oligomers in an α-Syn overexpressing cell model. Furthermore, NaHS rescued viability of A53T α-Syn overexpressing cells seeded with wt- and mutant preformed fibrils. These results support a conformation-specific effect of hydrogen sulfide on alpha-synuclein aggregation and cell viability which deserves further exploration for therapeutic potential.

Keywords: Hydrogen sulfide; Parkinson disease; Protein aggregation; α-Synuclein.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
α-Syn familial mutation effects on fibril amplification in vitro and aggregation within cells. (AC) Fibril formation kinetics of human α-Syn monitored by ThT. (A) Comparison of lag time for fibril growth of spontaneous (non-seeded) and (B) self-seeded aggregation of α-Syn monomer. (C) Comparison of lag time for fibril growth of cross-seeded aggregation of α-Syn monomer. Monomeric forms of recombinant wt-, A30P-, H50Q-, G51D- and A53T-α-Syn mutant were seeded with wt- and mutated α-Syn PFF. The results of ThT analysis represent the average of several experiments (at least n = 3, in some instances n = 5). Error bars represent S.E. *p < 0.05, **p < 0.005, ***p < 0.0005. ****p < 0.0001, ##p < 0.005. (D,E) Characterization of wt fibrillar α-Syn and fibrillar α-Syn bearing mutation at A30P, H50Q, G51D and A53T. (D) Representative TEM images of 1 µM wt α-Syn and α-Syn bearing mutation at A30P, H50Q, G51D and A53T fibrils. (E) α-Syn fiber length distribution. Fiber lengths for mutations are plotted against the same wt values for each graph. The figures are representative of three independent experiments with 3 grids analyzed per condition. (FH) Analysis of propagation of internalized wt- and mutated α-Syn PFF in HEK 293 T cells overexpressing α-Syn with familial point mutation A53T tagged with YFP (HEK 293 T A53T-YFP). Cells were transduced with 10 nM A30P-, H50Q-, G51D-, A53T-, and wt-α-Syn seeds for 24 h and 48 h. Inclusions were validated with confocal microscopy (Nikon Eclipse Ti2). (F) Representative confocal images of seeded HEK 293 T A53T-YFP cells for 24 h (Scale bar, 20 µm). (G) Histogram of the percentage of cells with α-Syn inclusions 24 h following transduction with 10 nM α-Syn seeds. Statistical significance is shown as **p < 0.005, ****p < 0.0001. (H) Representative confocal images of seeded cells transduced with 10 nM A30P-, H50Q-, G51D-, A53T-, and wt-αSyn for 48 h. For evaluation, three independent staining experiments were analyzed.
Fig. 2
Fig. 2
NaHS interferes with A53T aggregation in self- and cross-seeding paradigms by prolonging the lag phase and delaying fibril formation. (A) Comparison of lag time for fibril growth of wt-α-Syn monomer seeded with wt PFF and cross-seeded with α-Syn variants (A30P, H50Q, G51D and A53T) in the absence and presence of 1µM NaHS. (B) Comparison of lag time for fibril growth of A53T-α-Syn monomer self-seeded and cross-seeded with wt and α-Syn variants (A30P, H50Q, G51D) in the absence and presence of 1µM NaHS. Error bars represent. S.E. ***p < 0.0005. **** p < 0.0001. (C) ThT fluorescence traces for fibril formation of A53T α-Syn monomer seeded with wt PFF and A53T PFF in the absence and presence of 1 µM NaHS. The curve is the average of 3 independent experiments. (D) Representative dot blot of α-Syn in non-seeded QuIC samples in the absence and presence of NaHS (n = 3). α-Syn was detected using anti-α-Syn MJFR1 Ab. (E) Quantification of dot blot of αSyn in seeded QuIC samples in the absence and presence of 1µM NaHS (n = 2). α-Syn was detected using mouse anti-αSyn Ab clone 42 from BD Biosciences. (F) Representative Dot blot of α-Syn in PFF-seeded QuIC samples in the absence and presence of 1µM NaHS (n = 3). Control is non-seeded QuIC samples. α-Syn was detected using anti-α-Syn MJFR1 Ab. (G) Quantification of dot blot, each dot represents an individual sample. presence of 1 µM NaHS. (H,I) Representative dot blot and histogram analysis of wt- (n = 6) (H), and A53T α-Syn (n = 4) (I) in A53T-PFF-seeded QuIC samples in the absence and presence of 1µM NaHS. α-Syn was detected using anti-Alpha-synuclein aggregate antibody [MJFR-14–6-4–2]. Error bars represent. S.E. *p < 0.05. ****p < 0.0001.
Fig. 3
Fig. 3
Treatment with 1µM NaHS reduced mature fibril length. (A,B) Uranyl acetate-stained TEM micrographs of α-Syn fibrils generated by 3 days of shaking in the presence of NaHS. The wt-PFF and A53T-PFF acted as seeds to induce wt α-Syn (A) and A53T α-Syn (B) fibrilization in the absence and the presence of 1 µM NaHS. (CD) Fibril length distribution for wild-type α-Syn monomer seeded with either (C) wt-PFF or (D) A53T- PFF. (EF) Fibril length distribution for A53T α-Syn seeded with either (E) wt-PFF or (F) A53T-PFF. The figures are representative of three independent experiments with 3 grids analyzed per condition. (GI) Stability of α-Syn fibrils against proteolysis. Aggregation was carried out under QuIC conditions. PK digestion was performed at 37 °C at the indicated period. (G) Proteinase K (PK) resistance of wt- and A53T α-Syn fibers which were replicated in the absence of PFF seeding show no difference in PK resistance in the absence or the presence of 1 µM NaHS. (H) PK resistance of wt α-Syn fibrils formed by seeding with wt- and A53T-PFF in the absence and presence of 1 µM NaHS. (I) PK sensitivity of wt and A53T α-Syn fibrils produced by seeding with PFF under ThT conditions in the absence and presence of 1 µM NaHS. (J) α-Syn dot-blot immunostaining after proteinase K (PK)-digestion of wt α-Syn fibrils formed by seeding with wt- and A53T-PFF in the absence and presence of 1 µM NaHS. (K) Quantification of dot-blot, each dot represents an individual sample. (L) α-Syn dot-blot immunostaining after proteinase K (PK)-digestion of A53T α-Syn fibrils formed by seeding with wt- and A53T-PFF in the absence and presence of 1 µM NaHS. (M) Quantification of dot-blot, each dot represents an individual sample. presence of 1 µM NaHS. (M) Quantification of dot-blot, each dot represents an individual sample.
Fig. 4
Fig. 4
NaHS diminished intracellular seeding activity, size and cytotoxicity of α-Syn PFFs. (A) FRET efficiency values for HEK 293T A53T CFP/YFP as a measure of α-Syn aggregation. (B) Representative confocal images of HEK 293T A53T-YFP cells seeded with wt-PFF and treated with 1 µM NaHS. The seeding was validated with confocal microscopy (Nikon Eclipse Ti2). The cells were transduced with 1 nM wt-α-Syn seeds for 48 h. Statistical significance is shown as **p < 0.005, ****p < 0.0001. (CF) Visualization and analysis of oligomers (N-SIM, Nikon, with 100 × magnification) using Imaris (Bitplane) image analysis software. (C) Representative reconstructed 3D images of α-Syn aggregates formed in HEK293 A53T-YFP cells seeded with 1nM wt-PFF in the absence and the presence of 1 µM NaHS. (D) Number of aggregates per field. (E) Analysis of filament length. (F) Filament surface. Statistical significance is shown as *p < 0.05, **p < 0.005. (GI) NaHS suppresses α-Syn toxicity in HEK 293T (G), HEK 293T cells overexpressing A53T mutant (H), and SH-SY5Y (I) seeded with preformed fibrils. Cells were treated with either buffer or 1μM NaHS. Cytotoxicity was assessed by XTT assay after exposure to 10nM α-Syn wt and 10nM α-syn mutated at A30P, H50Q, G51D and A53T fibrils for 3 days. Statistical significance of 5 independent experiments is shown as *p < 0.05, **p < 0.005, ***p < 0.0005. ****p < 0.0001.

References

    1. Samii, A., Nutt, J. G. & Ransom, B. R. Parkinson’s disease. Lancet363, 1783–1793. 10.1016/S0140-6736(04)16305-8 (2004). - PubMed
    1. Bloem, B. R., Okun, M. S. & Klein, C. Parkinson’s disease. Lancet397, 2284–2303. 10.1016/S0140-6736(21)00218-X (2021). - PubMed
    1. Collaborators, G. B. D. Global, regional, and national burden of Parkinson’s disease, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol17, 939–953 (2018). 10.1016/S1474-4422(18)30295-3 - PMC - PubMed
    1. Ou, Z. et al. Global trends in the incidence, prevalence, and years lived with disability of Parkinson’s disease in 204 countries/territories from 1990 to 2019. Front. Public Health9, 776847. 10.3389/fpubh.2021.776847 (2021). - PMC - PubMed
    1. Willis, A. W. et al. Incidence of Parkinson disease in North America. NPJ Parkinsons Dis.8, 170. 10.1038/s41531-022-00410-y (2022). - PMC - PubMed

MeSH terms

LinkOut - more resources